nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Stomatitis—Etoposide—uterine cancer	0.00184	0.00184	CcSEcCtD
Tobramycin—Creatinine increased—Doxorubicin—uterine cancer	0.00184	0.00184	CcSEcCtD
Tobramycin—Malaise—Dactinomycin—uterine cancer	0.00184	0.00184	CcSEcCtD
Tobramycin—Leukopenia—Dactinomycin—uterine cancer	0.00183	0.00183	CcSEcCtD
Tobramycin—Agranulocytosis—Etoposide—uterine cancer	0.00176	0.00176	CcSEcCtD
Tobramycin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00176	CcSEcCtD
Tobramycin—Phosphatase alkaline increased—Doxorubicin—uterine cancer	0.00175	0.00175	CcSEcCtD
Tobramycin—Dry eye—Epirubicin—uterine cancer	0.00175	0.00175	CcSEcCtD
Tobramycin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00174	0.00174	CcSEcCtD
Tobramycin—Myalgia—Dactinomycin—uterine cancer	0.00174	0.00174	CcSEcCtD
Tobramycin—Hypersensitivity—Progesterone—uterine cancer	0.00173	0.00173	CcSEcCtD
Tobramycin—Rash maculo-papular—Epirubicin—uterine cancer	0.00172	0.00172	CcSEcCtD
Tobramycin—Discomfort—Dactinomycin—uterine cancer	0.00172	0.00172	CcSEcCtD
Tobramycin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.00169	CcSEcCtD
Tobramycin—Asthenia—Progesterone—uterine cancer	0.00169	0.00169	CcSEcCtD
Tobramycin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.00169	CcSEcCtD
Tobramycin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.00169	CcSEcCtD
Tobramycin—Urinary tract disorder—Etoposide—uterine cancer	0.00167	0.00167	CcSEcCtD
Tobramycin—Pruritus—Progesterone—uterine cancer	0.00167	0.00167	CcSEcCtD
Tobramycin—Urethral disorder—Etoposide—uterine cancer	0.00166	0.00166	CcSEcCtD
Tobramycin—Thrombocytopenia—Dactinomycin—uterine cancer	0.00163	0.00163	CcSEcCtD
Tobramycin—Dry eye—Doxorubicin—uterine cancer	0.00162	0.00162	CcSEcCtD
Tobramycin—Diarrhoea—Progesterone—uterine cancer	0.00161	0.00161	CcSEcCtD
Tobramycin—Rash maculo-papular—Doxorubicin—uterine cancer	0.00159	0.00159	CcSEcCtD
Tobramycin—Thrombophlebitis—Epirubicin—uterine cancer	0.00159	0.00159	CcSEcCtD
Tobramycin—Anorexia—Dactinomycin—uterine cancer	0.00159	0.00159	CcSEcCtD
Tobramycin—Eye disorder—Etoposide—uterine cancer	0.00158	0.00158	CcSEcCtD
Tobramycin—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.00158	0.00158	CcSEcCtD
Tobramycin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00157	0.00157	CcSEcCtD
Tobramycin—Dizziness—Progesterone—uterine cancer	0.00156	0.00156	CcSEcCtD
Tobramycin—Angiopathy—Etoposide—uterine cancer	0.00154	0.00154	CcSEcCtD
Tobramycin—Immune system disorder—Etoposide—uterine cancer	0.00153	0.00153	CcSEcCtD
Tobramycin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.00153	CcSEcCtD
Tobramycin—Mediastinal disorder—Etoposide—uterine cancer	0.00153	0.00153	CcSEcCtD
Tobramycin—Eye pain—Epirubicin—uterine cancer	0.00152	0.00152	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00152	0.00152	CcSEcCtD
Tobramycin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.00151	CcSEcCtD
Tobramycin—Vomiting—Progesterone—uterine cancer	0.0015	0.0015	CcSEcCtD
Tobramycin—Renal failure acute—Epirubicin—uterine cancer	0.00149	0.00149	CcSEcCtD
Tobramycin—Rash—Progesterone—uterine cancer	0.00148	0.00148	CcSEcCtD
Tobramycin—Dermatitis—Progesterone—uterine cancer	0.00148	0.00148	CcSEcCtD
Tobramycin—Headache—Progesterone—uterine cancer	0.00147	0.00147	CcSEcCtD
Tobramycin—Thrombophlebitis—Doxorubicin—uterine cancer	0.00147	0.00147	CcSEcCtD
Tobramycin—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.00146	0.00146	CcSEcCtD
Tobramycin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00146	CcSEcCtD
Tobramycin—Dermatitis exfoliative—Epirubicin—uterine cancer	0.00146	0.00146	CcSEcCtD
Tobramycin—Decreased appetite—Dactinomycin—uterine cancer	0.00145	0.00145	CcSEcCtD
Tobramycin—Dysgeusia—Etoposide—uterine cancer	0.00145	0.00145	CcSEcCtD
Tobramycin—Renal impairment—Epirubicin—uterine cancer	0.00144	0.00144	CcSEcCtD
Tobramycin—Back pain—Etoposide—uterine cancer	0.00143	0.00143	CcSEcCtD
Tobramycin—Pain—Dactinomycin—uterine cancer	0.00142	0.00142	CcSEcCtD
Tobramycin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.00141	CcSEcCtD
Tobramycin—Eye pain—Doxorubicin—uterine cancer	0.00141	0.00141	CcSEcCtD
Tobramycin—Lethargy—Epirubicin—uterine cancer	0.0014	0.0014	CcSEcCtD
Tobramycin—Nausea—Progesterone—uterine cancer	0.0014	0.0014	CcSEcCtD
Tobramycin—Renal failure acute—Doxorubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Tobramycin—Feeling abnormal—Dactinomycin—uterine cancer	0.00137	0.00137	CcSEcCtD
Tobramycin—Ill-defined disorder—Etoposide—uterine cancer	0.00137	0.00137	CcSEcCtD
Tobramycin—Anaemia—Etoposide—uterine cancer	0.00136	0.00136	CcSEcCtD
Tobramycin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00136	0.00136	CcSEcCtD
Tobramycin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00136	CcSEcCtD
Tobramycin—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.00135	0.00135	CcSEcCtD
Tobramycin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00135	CcSEcCtD
Tobramycin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00134	CcSEcCtD
Tobramycin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00134	CcSEcCtD
Tobramycin—Renal impairment—Doxorubicin—uterine cancer	0.00134	0.00134	CcSEcCtD
Tobramycin—Malaise—Etoposide—uterine cancer	0.00133	0.00133	CcSEcCtD
Tobramycin—Vertigo—Etoposide—uterine cancer	0.00133	0.00133	CcSEcCtD
Tobramycin—Leukopenia—Etoposide—uterine cancer	0.00132	0.00132	CcSEcCtD
Tobramycin—Abdominal pain—Dactinomycin—uterine cancer	0.00132	0.00132	CcSEcCtD
Tobramycin—Body temperature increased—Dactinomycin—uterine cancer	0.00132	0.00132	CcSEcCtD
Tobramycin—Lethargy—Doxorubicin—uterine cancer	0.0013	0.0013	CcSEcCtD
Tobramycin—Cough—Etoposide—uterine cancer	0.00129	0.00129	CcSEcCtD
Tobramycin—Blood creatinine increased—Epirubicin—uterine cancer	0.00129	0.00129	CcSEcCtD
Tobramycin—Dehydration—Epirubicin—uterine cancer	0.00128	0.00128	CcSEcCtD
Tobramycin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00127	CcSEcCtD
Tobramycin—Dry skin—Epirubicin—uterine cancer	0.00126	0.00126	CcSEcCtD
Tobramycin—Chest pain—Etoposide—uterine cancer	0.00126	0.00126	CcSEcCtD
Tobramycin—Hypokalaemia—Epirubicin—uterine cancer	0.00125	0.00125	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00125	0.00125	CcSEcCtD
Tobramycin—Discomfort—Etoposide—uterine cancer	0.00124	0.00124	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.00124	0.00124	CcSEcCtD
Tobramycin—Hypersensitivity—Dactinomycin—uterine cancer	0.00123	0.00123	CcSEcCtD
Tobramycin—Confusional state—Etoposide—uterine cancer	0.00121	0.00121	CcSEcCtD
Tobramycin—Muscular weakness—Epirubicin—uterine cancer	0.00121	0.00121	CcSEcCtD
Tobramycin—Anaphylactic shock—Etoposide—uterine cancer	0.0012	0.0012	CcSEcCtD
Tobramycin—Asthenia—Dactinomycin—uterine cancer	0.00119	0.00119	CcSEcCtD
Tobramycin—Blood creatinine increased—Doxorubicin—uterine cancer	0.00119	0.00119	CcSEcCtD
Tobramycin—Asthma—Epirubicin—uterine cancer	0.00119	0.00119	CcSEcCtD
Tobramycin—Dehydration—Doxorubicin—uterine cancer	0.00118	0.00118	CcSEcCtD
Tobramycin—Thrombocytopenia—Etoposide—uterine cancer	0.00118	0.00118	CcSEcCtD
Tobramycin—Eosinophilia—Epirubicin—uterine cancer	0.00118	0.00118	CcSEcCtD
Tobramycin—Skin disorder—Etoposide—uterine cancer	0.00117	0.00117	CcSEcCtD
Tobramycin—Dry skin—Doxorubicin—uterine cancer	0.00116	0.00116	CcSEcCtD
Tobramycin—Hypokalaemia—Doxorubicin—uterine cancer	0.00116	0.00116	CcSEcCtD
Tobramycin—Anorexia—Etoposide—uterine cancer	0.00115	0.00115	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.00114	0.00114	CcSEcCtD
Tobramycin—Bronchitis—Epirubicin—uterine cancer	0.00114	0.00114	CcSEcCtD
Tobramycin—Diarrhoea—Dactinomycin—uterine cancer	0.00114	0.00114	CcSEcCtD
Tobramycin—Muscular weakness—Doxorubicin—uterine cancer	0.00112	0.00112	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Epirubicin—uterine cancer	0.0011	0.0011	CcSEcCtD
Tobramycin—Asthma—Doxorubicin—uterine cancer	0.0011	0.0011	CcSEcCtD
Tobramycin—Eosinophilia—Doxorubicin—uterine cancer	0.00109	0.00109	CcSEcCtD
Tobramycin—Paraesthesia—Etoposide—uterine cancer	0.00108	0.00108	CcSEcCtD
Tobramycin—Weight decreased—Epirubicin—uterine cancer	0.00107	0.00107	CcSEcCtD
Tobramycin—Dyspnoea—Etoposide—uterine cancer	0.00107	0.00107	CcSEcCtD
Tobramycin—Infestation—Epirubicin—uterine cancer	0.00106	0.00106	CcSEcCtD
Tobramycin—Infestation NOS—Epirubicin—uterine cancer	0.00106	0.00106	CcSEcCtD
Tobramycin—Vomiting—Dactinomycin—uterine cancer	0.00106	0.00106	CcSEcCtD
Tobramycin—Bronchitis—Doxorubicin—uterine cancer	0.00106	0.00106	CcSEcCtD
Tobramycin—Rash—Dactinomycin—uterine cancer	0.00105	0.00105	CcSEcCtD
Tobramycin—Decreased appetite—Etoposide—uterine cancer	0.00105	0.00105	CcSEcCtD
Tobramycin—Renal failure—Epirubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Etoposide—uterine cancer	0.00104	0.00104	CcSEcCtD
Tobramycin—Neuropathy peripheral—Epirubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Tobramycin—Stomatitis—Epirubicin—uterine cancer	0.00103	0.00103	CcSEcCtD
Tobramycin—Pain—Etoposide—uterine cancer	0.00103	0.00103	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.00102	0.00102	CcSEcCtD
Tobramycin—Epistaxis—Epirubicin—uterine cancer	0.000998	0.000998	CcSEcCtD
Tobramycin—Weight decreased—Doxorubicin—uterine cancer	0.000994	0.000994	CcSEcCtD
Tobramycin—Sinusitis—Epirubicin—uterine cancer	0.000993	0.000993	CcSEcCtD
Tobramycin—Feeling abnormal—Etoposide—uterine cancer	0.000992	0.000992	CcSEcCtD
Tobramycin—Nausea—Dactinomycin—uterine cancer	0.000988	0.000988	CcSEcCtD
Tobramycin—Agranulocytosis—Epirubicin—uterine cancer	0.000988	0.000988	CcSEcCtD
Tobramycin—Gastrointestinal pain—Etoposide—uterine cancer	0.000985	0.000985	CcSEcCtD
Tobramycin—Infestation NOS—Doxorubicin—uterine cancer	0.000979	0.000979	CcSEcCtD
Tobramycin—Infestation—Doxorubicin—uterine cancer	0.000979	0.000979	CcSEcCtD
Tobramycin—Renal failure—Doxorubicin—uterine cancer	0.000963	0.000963	CcSEcCtD
Tobramycin—Neuropathy peripheral—Doxorubicin—uterine cancer	0.00096	0.00096	CcSEcCtD
Tobramycin—Urticaria—Etoposide—uterine cancer	0.000957	0.000957	CcSEcCtD
Tobramycin—Stomatitis—Doxorubicin—uterine cancer	0.000955	0.000955	CcSEcCtD
Tobramycin—Rhinitis—Epirubicin—uterine cancer	0.000953	0.000953	CcSEcCtD
Tobramycin—Body temperature increased—Etoposide—uterine cancer	0.000952	0.000952	CcSEcCtD
Tobramycin—Abdominal pain—Etoposide—uterine cancer	0.000952	0.000952	CcSEcCtD
Tobramycin—Pharyngitis—Epirubicin—uterine cancer	0.000943	0.000943	CcSEcCtD
Tobramycin—Urinary tract disorder—Epirubicin—uterine cancer	0.000938	0.000938	CcSEcCtD
Tobramycin—Connective tissue disorder—Epirubicin—uterine cancer	0.000934	0.000934	CcSEcCtD
Tobramycin—Urethral disorder—Epirubicin—uterine cancer	0.000931	0.000931	CcSEcCtD
Tobramycin—Epistaxis—Doxorubicin—uterine cancer	0.000924	0.000924	CcSEcCtD
Tobramycin—Sinusitis—Doxorubicin—uterine cancer	0.000919	0.000919	CcSEcCtD
Tobramycin—Visual impairment—Epirubicin—uterine cancer	0.000916	0.000916	CcSEcCtD
Tobramycin—Agranulocytosis—Doxorubicin—uterine cancer	0.000914	0.000914	CcSEcCtD
Tobramycin—Eye disorder—Epirubicin—uterine cancer	0.000888	0.000888	CcSEcCtD
Tobramycin—Hypersensitivity—Etoposide—uterine cancer	0.000887	0.000887	CcSEcCtD
Tobramycin—Tinnitus—Epirubicin—uterine cancer	0.000886	0.000886	CcSEcCtD
Tobramycin—Rhinitis—Doxorubicin—uterine cancer	0.000881	0.000881	CcSEcCtD
Tobramycin—Pharyngitis—Doxorubicin—uterine cancer	0.000873	0.000873	CcSEcCtD
Tobramycin—Urinary tract disorder—Doxorubicin—uterine cancer	0.000868	0.000868	CcSEcCtD
Tobramycin—Asthenia—Etoposide—uterine cancer	0.000864	0.000864	CcSEcCtD
Tobramycin—Connective tissue disorder—Doxorubicin—uterine cancer	0.000864	0.000864	CcSEcCtD
Tobramycin—Angiopathy—Epirubicin—uterine cancer	0.000862	0.000862	CcSEcCtD
Tobramycin—Urethral disorder—Doxorubicin—uterine cancer	0.000862	0.000862	CcSEcCtD
Tobramycin—Immune system disorder—Epirubicin—uterine cancer	0.000858	0.000858	CcSEcCtD
Tobramycin—Mediastinal disorder—Epirubicin—uterine cancer	0.000856	0.000856	CcSEcCtD
Tobramycin—Pruritus—Etoposide—uterine cancer	0.000852	0.000852	CcSEcCtD
Tobramycin—Visual impairment—Doxorubicin—uterine cancer	0.000847	0.000847	CcSEcCtD
Tobramycin—Erythema—Epirubicin—uterine cancer	0.000827	0.000827	CcSEcCtD
Tobramycin—Diarrhoea—Etoposide—uterine cancer	0.000824	0.000824	CcSEcCtD
Tobramycin—Eye disorder—Doxorubicin—uterine cancer	0.000822	0.000822	CcSEcCtD
Tobramycin—Tinnitus—Doxorubicin—uterine cancer	0.00082	0.00082	CcSEcCtD
Tobramycin—Dysgeusia—Epirubicin—uterine cancer	0.00081	0.00081	CcSEcCtD
Tobramycin—Back pain—Epirubicin—uterine cancer	0.0008	0.0008	CcSEcCtD
Tobramycin—Angiopathy—Doxorubicin—uterine cancer	0.000798	0.000798	CcSEcCtD
Tobramycin—Dizziness—Etoposide—uterine cancer	0.000796	0.000796	CcSEcCtD
Tobramycin—Immune system disorder—Doxorubicin—uterine cancer	0.000794	0.000794	CcSEcCtD
Tobramycin—Mediastinal disorder—Doxorubicin—uterine cancer	0.000792	0.000792	CcSEcCtD
Tobramycin—Vision blurred—Epirubicin—uterine cancer	0.00078	0.00078	CcSEcCtD
Tobramycin—Ill-defined disorder—Epirubicin—uterine cancer	0.000767	0.000767	CcSEcCtD
Tobramycin—Vomiting—Etoposide—uterine cancer	0.000766	0.000766	CcSEcCtD
Tobramycin—Erythema—Doxorubicin—uterine cancer	0.000765	0.000765	CcSEcCtD
Tobramycin—Anaemia—Epirubicin—uterine cancer	0.000765	0.000765	CcSEcCtD
Tobramycin—Rash—Etoposide—uterine cancer	0.000759	0.000759	CcSEcCtD
Tobramycin—Dermatitis—Etoposide—uterine cancer	0.000759	0.000759	CcSEcCtD
Tobramycin—Headache—Etoposide—uterine cancer	0.000754	0.000754	CcSEcCtD
Tobramycin—Dysgeusia—Doxorubicin—uterine cancer	0.00075	0.00075	CcSEcCtD
Tobramycin—Malaise—Epirubicin—uterine cancer	0.000746	0.000746	CcSEcCtD
Tobramycin—Vertigo—Epirubicin—uterine cancer	0.000743	0.000743	CcSEcCtD
Tobramycin—Leukopenia—Epirubicin—uterine cancer	0.00074	0.00074	CcSEcCtD
Tobramycin—Back pain—Doxorubicin—uterine cancer	0.00074	0.00074	CcSEcCtD
Tobramycin—Cough—Epirubicin—uterine cancer	0.000722	0.000722	CcSEcCtD
Tobramycin—Vision blurred—Doxorubicin—uterine cancer	0.000721	0.000721	CcSEcCtD
Tobramycin—Nausea—Etoposide—uterine cancer	0.000715	0.000715	CcSEcCtD
Tobramycin—Ill-defined disorder—Doxorubicin—uterine cancer	0.00071	0.00071	CcSEcCtD
Tobramycin—Anaemia—Doxorubicin—uterine cancer	0.000707	0.000707	CcSEcCtD
Tobramycin—Myalgia—Epirubicin—uterine cancer	0.000704	0.000704	CcSEcCtD
Tobramycin—Chest pain—Epirubicin—uterine cancer	0.000704	0.000704	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000699	0.000699	CcSEcCtD
Tobramycin—Discomfort—Epirubicin—uterine cancer	0.000696	0.000696	CcSEcCtD
Tobramycin—Malaise—Doxorubicin—uterine cancer	0.00069	0.00069	CcSEcCtD
Tobramycin—Vertigo—Doxorubicin—uterine cancer	0.000688	0.000688	CcSEcCtD
Tobramycin—Leukopenia—Doxorubicin—uterine cancer	0.000685	0.000685	CcSEcCtD
Tobramycin—Confusional state—Epirubicin—uterine cancer	0.000681	0.000681	CcSEcCtD
Tobramycin—Anaphylactic shock—Epirubicin—uterine cancer	0.000675	0.000675	CcSEcCtD
Tobramycin—Cough—Doxorubicin—uterine cancer	0.000668	0.000668	CcSEcCtD
Tobramycin—Nervous system disorder—Epirubicin—uterine cancer	0.000662	0.000662	CcSEcCtD
Tobramycin—Thrombocytopenia—Epirubicin—uterine cancer	0.000661	0.000661	CcSEcCtD
Tobramycin—Skin disorder—Epirubicin—uterine cancer	0.000656	0.000656	CcSEcCtD
Tobramycin—Chest pain—Doxorubicin—uterine cancer	0.000652	0.000652	CcSEcCtD
Tobramycin—Myalgia—Doxorubicin—uterine cancer	0.000652	0.000652	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000647	0.000647	CcSEcCtD
Tobramycin—Discomfort—Doxorubicin—uterine cancer	0.000644	0.000644	CcSEcCtD
Tobramycin—Anorexia—Epirubicin—uterine cancer	0.000644	0.000644	CcSEcCtD
Tobramycin—Confusional state—Doxorubicin—uterine cancer	0.00063	0.00063	CcSEcCtD
Tobramycin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000625	0.000625	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000615	0.000615	CcSEcCtD
Tobramycin—Nervous system disorder—Doxorubicin—uterine cancer	0.000613	0.000613	CcSEcCtD
Tobramycin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000612	0.000612	CcSEcCtD
Tobramycin—Skin disorder—Doxorubicin—uterine cancer	0.000607	0.000607	CcSEcCtD
Tobramycin—Paraesthesia—Epirubicin—uterine cancer	0.000606	0.000606	CcSEcCtD
Tobramycin—Dyspnoea—Epirubicin—uterine cancer	0.000602	0.000602	CcSEcCtD
Tobramycin—Anorexia—Doxorubicin—uterine cancer	0.000595	0.000595	CcSEcCtD
Tobramycin—Decreased appetite—Epirubicin—uterine cancer	0.000587	0.000587	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000583	0.000583	CcSEcCtD
Tobramycin—Pain—Epirubicin—uterine cancer	0.000577	0.000577	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000569	0.000569	CcSEcCtD
Tobramycin—Paraesthesia—Doxorubicin—uterine cancer	0.000561	0.000561	CcSEcCtD
Tobramycin—Dyspnoea—Doxorubicin—uterine cancer	0.000557	0.000557	CcSEcCtD
Tobramycin—Feeling abnormal—Epirubicin—uterine cancer	0.000556	0.000556	CcSEcCtD
Tobramycin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000552	0.000552	CcSEcCtD
Tobramycin—Decreased appetite—Doxorubicin—uterine cancer	0.000543	0.000543	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000539	0.000539	CcSEcCtD
Tobramycin—Urticaria—Epirubicin—uterine cancer	0.000536	0.000536	CcSEcCtD
Tobramycin—Pain—Doxorubicin—uterine cancer	0.000534	0.000534	CcSEcCtD
Tobramycin—Abdominal pain—Epirubicin—uterine cancer	0.000534	0.000534	CcSEcCtD
Tobramycin—Body temperature increased—Epirubicin—uterine cancer	0.000534	0.000534	CcSEcCtD
Tobramycin—Feeling abnormal—Doxorubicin—uterine cancer	0.000515	0.000515	CcSEcCtD
Tobramycin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000511	0.000511	CcSEcCtD
Tobramycin—Hypersensitivity—Epirubicin—uterine cancer	0.000497	0.000497	CcSEcCtD
Tobramycin—Urticaria—Doxorubicin—uterine cancer	0.000496	0.000496	CcSEcCtD
Tobramycin—Body temperature increased—Doxorubicin—uterine cancer	0.000494	0.000494	CcSEcCtD
Tobramycin—Abdominal pain—Doxorubicin—uterine cancer	0.000494	0.000494	CcSEcCtD
Tobramycin—Asthenia—Epirubicin—uterine cancer	0.000484	0.000484	CcSEcCtD
Tobramycin—Pruritus—Epirubicin—uterine cancer	0.000478	0.000478	CcSEcCtD
Tobramycin—Diarrhoea—Epirubicin—uterine cancer	0.000462	0.000462	CcSEcCtD
Tobramycin—Hypersensitivity—Doxorubicin—uterine cancer	0.00046	0.00046	CcSEcCtD
Tobramycin—Asthenia—Doxorubicin—uterine cancer	0.000448	0.000448	CcSEcCtD
Tobramycin—Dizziness—Epirubicin—uterine cancer	0.000446	0.000446	CcSEcCtD
Tobramycin—Pruritus—Doxorubicin—uterine cancer	0.000442	0.000442	CcSEcCtD
Tobramycin—Vomiting—Epirubicin—uterine cancer	0.000429	0.000429	CcSEcCtD
Tobramycin—Diarrhoea—Doxorubicin—uterine cancer	0.000427	0.000427	CcSEcCtD
Tobramycin—Rash—Epirubicin—uterine cancer	0.000426	0.000426	CcSEcCtD
Tobramycin—Dermatitis—Epirubicin—uterine cancer	0.000425	0.000425	CcSEcCtD
Tobramycin—Headache—Epirubicin—uterine cancer	0.000423	0.000423	CcSEcCtD
Tobramycin—Dizziness—Doxorubicin—uterine cancer	0.000413	0.000413	CcSEcCtD
Tobramycin—Nausea—Epirubicin—uterine cancer	0.000401	0.000401	CcSEcCtD
Tobramycin—Vomiting—Doxorubicin—uterine cancer	0.000397	0.000397	CcSEcCtD
Tobramycin—Rash—Doxorubicin—uterine cancer	0.000394	0.000394	CcSEcCtD
Tobramycin—Dermatitis—Doxorubicin—uterine cancer	0.000393	0.000393	CcSEcCtD
Tobramycin—Headache—Doxorubicin—uterine cancer	0.000391	0.000391	CcSEcCtD
Tobramycin—Nausea—Doxorubicin—uterine cancer	0.000371	0.000371	CcSEcCtD
